Tags

Type your tag names separated by a space and hit enter

Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
Euro Surveill. 2013 Feb 14; 18(7):3.ES

Abstract

We conducted a test-negative case-control study based in five European sentinel surveillance networks. The early 2012/13 adjusted influenza vaccine effectiveness was 78.2% (95% CI: 18.0 to 94.2) against influenza B, 62.1% (95% CI: -22.9 to 88.3%) against A(H1) pdm09, 41.9 (95% CI: -67.1 to 79.8) against A(H3N2) and 50.4% (95% CI: -20.7 to 79.6) against all influenza types in the target groups for vaccination. Efforts to improve influenza vaccines should continue to better protect those at risk of severe illness or complications.

Authors+Show Affiliations

EpiConcept, Paris, France. m.valenciano@epiconcept.frNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23449183

Citation

Valenciano, M, et al. "Early Estimates of Seasonal Influenza Vaccine Effectiveness in Europe: Results From the I-MOVE Multicentre Case-control Study, 2012/13." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 18, no. 7, 2013, p. 3.
Valenciano M, Kissling E, I-MOVE Case-Control Study Team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill. 2013;18(7):3.
Valenciano, M., & Kissling, E. (2013). Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 18(7), 3.
Valenciano M, Kissling E, I-MOVE Case-Control Study Team. Early Estimates of Seasonal Influenza Vaccine Effectiveness in Europe: Results From the I-MOVE Multicentre Case-control Study, 2012/13. Euro Surveill. 2013 Feb 14;18(7):3. PubMed PMID: 23449183.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. AU - Valenciano,M, AU - Kissling,E, AU - ,, Y1 - 2013/02/14/ PY - 2013/3/2/entrez PY - 2013/3/2/pubmed PY - 2013/4/25/medline SP - 3 EP - 3 JF - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin JO - Euro Surveill. VL - 18 IS - 7 N2 - We conducted a test-negative case-control study based in five European sentinel surveillance networks. The early 2012/13 adjusted influenza vaccine effectiveness was 78.2% (95% CI: 18.0 to 94.2) against influenza B, 62.1% (95% CI: -22.9 to 88.3%) against A(H1) pdm09, 41.9 (95% CI: -67.1 to 79.8) against A(H3N2) and 50.4% (95% CI: -20.7 to 79.6) against all influenza types in the target groups for vaccination. Efforts to improve influenza vaccines should continue to better protect those at risk of severe illness or complications. SN - 1560-7917 UR - https://www.unboundmedicine.com/medline/citation/23449183/Early_estimates_of_seasonal_influenza_vaccine_effectiveness_in_Europe:_results_from_the_I_MOVE_multicentre_case_control_study_2012/13_ L2 - http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20400 DB - PRIME DP - Unbound Medicine ER -